Patent · US Active

Compositions and methods for treating cancer

US10744141B2 · kind B2 · utility

0Cited by
3References
14Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJun 23, 2016
Grant dateAug 18, 2020
Priority date
Expiry dateJun 23, 2036

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method of treating cancer in a subject in need thereof includes administering to the subject therapeutically effective amounts of a PP2A activator and a protein kinase inhibitor.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.